SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-021493
Filing Date
2023-03-20
Accepted
2023-03-20 17:59:47
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-60958.html 4  
1 PRIMARY DOCUMENT marketforms-60958.xml 4 4182
  Complete submission text file 0001213900-23-021493.txt   5705
Mailing Address PONIARD PHARMACEUTICALS, INC. 750 BATTERY STREET, SUITE 330 SAN FRANCISCO CA 94111
Business Address
MARTELL RON (Reporting) CIK: 0001177079 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39138 | Film No.: 23747363

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)